Timeline

April 2024

Results from Pilot Phase of EPISODE Published by Academic Emergency Medicine. Results Reveal Harmony Can Reliably Identify LVO Stroke in the Prehospital Setting

December 2023

Successful Completion of Enrollment in EPISODE-VS hEadpulse for Ischemic StrOke DEtection Prehospital Study

October 2023

Dr. Wade Smith MD, PhD, Presents HeadPulse Sleep Burst Data at the World Sleep Congress Meeting in Rio de Janeiro

October 2023

FDA grants Breakthrough Device Designation for Harmony

October 2023

Best Abstract of the Year Awarded to Dr. James Paxton MD, Primary Investigator of “hEadPulse for Ischemic StrOke DEtection Prehospital Study During the COVID-19 Pandemic by American College of Emergency Physicians

August 2023

"Analysis of HeadPulse Biometric Measures Following Concussion In Young Adult Athletes" Published in JAMA Network Open

June 2023

First Patient Enrolled in Pivotal FDA Portion of EPISODE Prehospital LVO Stroke Triage Study

March 2023

Validation of HeadPulse in Recently Concussed Athletes Manuscript Submitted For Publication Officially Entitled:

"Analysis of HeadPulse Biometric Measures Following Concussion in Young Adult Athletes"

March 2023

Preliminary Results Published in Journal of Stroke Vascular Interventional Neurology of EPISODE-The First Prehospital Study of a Stroke Device

January 2023

Pilot Phase of EPISODE Prehospital Stroke Triage Study Completed

November 2022

Preliminary Results of EPISODE Prehospital Study Presented at SVIN

August 2022

EPISODE Prehospital Stroke Study on Stroke Triage Site Expansion to UCSF and CPMC Approved

June 2022

Generation 5.0 Harmony Headset Introduced to EPISODE Prehospital Stroke Study on Stroke Triage

January 2022

EPISODE Prehospital Stroke Study on Stroke Triage Site Expands to Western Michigan and Kalamazoo

October 2021

Second Generation 5.0 Headset Designed with Enhancements Informed by User Feedback from Pilot Phase of EPISODE Study

April 2021

First Patient Enrolled in EPISODE Prehospital Stroke Study on Stroke Triage

March 2021

FDA Strategy and Device Development with MRC Global and Starfish Group

February 2021

Pilot Phase of EPISODE Prehospital Stroke Study on Stroke Triage Begins in Detroit at Wayne State University

January 2021

Formation of Board

Corey Goodman appointed Chairman

December 2020

Executed License Agreement with UCSF for Research and Commercialization in Stroke

November 2020

Completion of Generation 4.0 Headset

July 2019

MindRhythm Incorporated

MindRhythm Completes Enrollment in its Multicenter Prehospital Trial for Identifying Large Vessel Occlusion Stroke

By Beth Johnson | December 4, 2023 |

December 4, 2023 MindRhythm Incorporated, a neurodiagnostic technology company based out of Cupertino, California, today announced that it reached the number of patients required to complete enrollment in its pivotal stroke trial-EPISODE. This trial was designed to validate that MindRhythm’s Harmony can accurately identify LVO stroke prehospital, with the goal of improving triage decisions. Better quality…

Harmony, MindRhythm’s Innovative Device for LVO Stroke, Granted Breakthrough Device Designation by the FDA

By Beth Johnson | November 1, 2023 |

The FDA has awarded a Breakthrough Device Designation for MindRhythm’s Harmony headset embedded with HeadPulse technology. The function of MindRhythm’s Harmony device is to aid in the assessment of suspected stroke patients in the prehospital setting to determine whether the patient may have a large vessel occlusion (LVO) stroke. LVO strokes are among the most…

MindRhythm Announces Publication in JAMA Network Open of Novel Headset for Return to Play Decisions in Concussion

By Beth Johnson | September 1, 2023 |

CUPERTINO, CALIFORNIA, UNITED STATES, August 11, 2023/EINPresswire.com/ — MindRhythm Inc, in collaboration with the University of California San Francisco (UCSF), announces publication of the manuscript titled “Analysis of HeadPulse Biometric Measures Following Concussion in Young Adult Athletes” released today in the journal, JAMA Network Open. The findings indicate that digital measurement of the HeadPulse, using MindRhythm’s proprietary…

EMS World: How a Simple Headset Can Solve the Triage Problem in Stroke

By John Keane | July 20, 2023 |

In an article published by EMS World back in June of 2021, it was postulated that MindRhythm’s rapid, disposable, noninvasive Harmony headset could detect Large Vessel Occlusion strokes in the field.  At the time, MindRhythm had preliminary, hospital-based data suggesting the device could accurately identify LVO strokes.  However, the company felt strongly that it was important to…

MindRhythm Announces First Patient Enrolled in Pivotal Study of Novel Harmony™ Device for Rapid Detection of Stroke

By Beth Johnson | June 20, 2023 |

CUPERTINO, CALIFORNIA, USA, June 20, 2023/EINPresswire.com/ — MindRhythm Inc, in partnership with Wayne State University School of Medicine in Detroit, Michigan, today announced that the first patient has been enrolled in the pivotal portion of its HeadPulse for Ischemic Stroke Detection Prehospital Study (EPISODE-VS). EPISODE-VS is designed to validate that the use of MindRhythm’s proprietary Harmony headset…

CEO John Keane Featured on NPR for Comment on SVB Crisis and Its Impact on Emerging Businesses

By Beth Johnson | April 3, 2023 |

Days after Silicon Valley Bank’s collapse prompted customers to line up in order to get their money out, the California bank is asking them to come back. “The number one thing you can do to support the future of this institution is to help us rebuild our deposit base, both by leaving deposits with Silicon Valley Bridge…

The Journal of Stroke Vascular and Interventional Neurology Publishes EPISODE-PS Initial Trial Results

By Beth Johnson | March 16, 2023 |

CUPERTINO, CALIFORNIA, UNITED STATES, March 16, 2023 /EINPresswire.com/ — MindRhythm Inc, in partnership with Wayne State University School of Medicine in Detroit, Michigan, today announces the first publication of results from the hEadPulse for Ischemic StrOke DEtection Prehospital Study (EPISODE-PS) trial.  The EPISODE-PS trial was designed to evaluate the use of MindRhythm’s proprietary Harmony headset…

MindRhythm Initiates Pivotal Portion of Prehospital Stroke Trial

By Beth Johnson | February 15, 2023 |

CUPERTINO, CALIFORNIA, UNITED STATES, February 14, 2023 /EINPresswire.com/ — MindRhythm Inc, in partnership with Wayne State University School of Medicine in Detroit, Michigan, today announces the conclusion of phase I and initiation of the pivotal portion of its hEadPulse for Ischemic StrOke DEtection Prehospital Study (EPISODE-VS). The EPISODE trial is designed to evaluate the use of MindRhythm’s…

MindRhythm Expands Stroke License to Include Diagnosis and Recovery From Concussion

By Beth Johnson | October 26, 2022 |

MindRhythm, a medical device technology company focused on preventing neurological injury, announces today the expansion of its exclusive worldwide stroke licensing agreement with University of California San Francisco (UCSF) to include concussion. The agreement was originally executed in December 2020 to support the successful development of MindRhythm’s Harmony headset for the detection of stroke following…

MindRhythm Expands EMS Stroke Trial to California

By Beth Johnson | October 11, 2022 |

MindRhythm, a medical device technology company focused on preventing neurological injury, announces today the expansion of part 1 of its first multicenter clinical trial in stroke to 2 additional sites in California. The trial is based out of Wayne State University in Detroit, in partnership with Henry Ford, Detroit Receiving, Sinai-Grace, and Ascension St. John…

Timeline

December 2023

Successful Completion of Enrollment in EPISODE-VS hEadpulse for Ischemic StrOke DEtection Prehospital Trial

October 2023

Dr. Wade Smith MD, PhD, presents HeadPulse Sleep Burst Data at the World Sleep Congress meeting in Rio de Janeiro

October 2023

FDA grants Breakthrough Device Designation for Harmony

October 2023

Best Abstract of the Year Awarded to Dr. James Paxton MD, Primary Investigator of “hEadPulse for Ischemic StrOke DEtection Prehospital Study During the COVID-19 Pandemic by American College of Emergency Physicians

August 2023

"Analysis of HeadPulse Biometric Measures Following Concussion In Young Adult Athletes" Published in JAMA Network Open

June 2023

First Patient Enrolled in Pivotal FDA Portion of EPISODE Prehospital LVO Stroke Triage Trial

March 2023

Validation of HeadPulse in Recently Concussed Athletes Manuscript Submitted For Publication Officially Entitled:

"Analysis of HeadPulse Biometric Measures Following Concussion in Young Adult Athletes"

March 2023

Preliminary Results Published in Journal of Stroke Vascular Interventional Neurology of EPISODE-The First Prehospital Study of a Stroke Device

January 2023

Phase I of EPISODE Prehospital Stroke Triage Trial Completed

November 2022

Preliminary Results of EPISODE Prehospital Trial Presented at SVIN

August 2022

EPISODE Prehospital Stroke Trial on Stroke Triage Site Expansion to UCSF and CPMC Approved

June 2022

Generation 5.0 Harmony Headset Introduced to EPISODE Prehospital  Stroke Trial on Stroke Triage

January 2022

EPISODE Prehospital Stroke Trial on Stroke Triage Site Expands to Western Michigan and Kalamazoo

October 2021

Second Generation 5.0 Headset Designed with Enhancements Informed by Episode Trial

April 2021

First Patient Enrolled in EPISODE Prehospital Stroke Trial on Stroke Triage

March 2021

FDA Strategy and Device Development with MRC Global and Starfish Group

February 2021

Part 1 of EPISODE Prehospital Stroke Trial on Stroke Triage Begins in Detroit at Wayne State University

January 2021

Formation of Board

Corey Goodman appointed Chairman

December 2020

Executed License Agreement with UCSF for Research and Commercialization in Stroke

November 2020

Completion of Generation 4.0 Headset

July 2019

MindRhythm Incorporated

Timeline

December 2023

Successful Completion of Enrollment in EPISODE-VS hEadpulse for Ischemic StrOke DEtection Prehospital Trial

October 2023

Dr. Wade Smith MD, PhD, presents HeadPulse Sleep Burst Data at the World Sleep Congress meeting in Rio de Janeiro

October 2023

FDA grants Breakthrough Device Designation for Harmony

October 2023

Best Abstract of the Year Awarded to Dr. James Paxton MD, Primary Investigator of “hEadPulse for Ischemic StrOke DEtection Prehospital Study During the COVID-19 Pandemic by American College of Emergency Physicians

August 2023

"Analysis of HeadPulse Biometric Measures Following Concussion In Young Adult Athletes" Published in JAMA Network Open

June 2023

First Patient Enrolled in Pivotal FDA Portion of EPISODE Prehospital LVO Stroke Triage Trial

March 2023

Validation of HeadPulse in Recently Concussed Athletes Manuscript Submitted For Publication Officially Entitled:

"Analysis of HeadPulse Biometric Measures Following Concussion in Young Adult Athletes"

March 2023

Preliminary Results Published in Journal of Stroke Vascular Interventional Neurology of EPISODE-The First Prehospital Study of a Stroke Device

January 2023

Phase I of EPISODE Prehospital Stroke Triage Trial Completed

November 2022

Preliminary Results of EPISODE Prehospital Trial Presented at SVIN

August 2022

EPISODE Prehospital Stroke Trial on Stroke Triage Site Expansion to UCSF and CPMC Approved

June 2022

Generation 5.0 Harmony Headset Introduced to EPISODE Prehospital  Stroke Trial on Stroke Triage

January 2022

EPISODE Prehospital Stroke Trial on Stroke Triage Site Expands to Western Michigan and Kalamazoo

October 2021

Second Generation 5.0 Headset Designed with Enhancements Informed by Episode Trial

April 2021

First Patient Enrolled in EPISODE Prehospital Stroke Trial on Stroke Triage

March 2021

FDA Strategy and Device Development with MRC Global and Starfish Group

February 2021

Part 1 of EPISODE Prehospital Stroke Trial on Stroke Triage Begins in Detroit at Wayne State University

January 2021

Formation of Board

Corey Goodman appointed Chairman

December 2020

Executed License Agreement with UCSF for Research and Commercialization in Stroke

November 2020

Completion of Generation 4.0 Headset

July 2019

MindRhythm Incorporated

MindRhythm Completes Enrollment in its Multicenter Prehospital Trial for Identifying Large Vessel Occlusion Stroke

By Beth Johnson | December 4, 2023 |

December 4, 2023 MindRhythm Incorporated, a neurodiagnostic technology company based out of Cupertino, California, today announced that it reached the number of patients required to complete enrollment in its pivotal stroke trial-EPISODE. This trial was designed to validate that MindRhythm’s Harmony can accurately identify LVO stroke prehospital, with the goal of improving triage decisions. Better quality…

Harmony, MindRhythm’s Innovative Device for LVO Stroke, Granted Breakthrough Device Designation by the FDA

By Beth Johnson | November 1, 2023 |

The FDA has awarded a Breakthrough Device Designation for MindRhythm’s Harmony headset embedded with HeadPulse technology. The function of MindRhythm’s Harmony device is to aid in the assessment of suspected stroke patients in the prehospital setting to determine whether the patient may have a large vessel occlusion (LVO) stroke. LVO strokes are among the most…

MindRhythm Announces Publication in JAMA Network Open of Novel Headset for Return to Play Decisions in Concussion

By Beth Johnson | September 1, 2023 |

CUPERTINO, CALIFORNIA, UNITED STATES, August 11, 2023/EINPresswire.com/ — MindRhythm Inc, in collaboration with the University of California San Francisco (UCSF), announces publication of the manuscript titled “Analysis of HeadPulse Biometric Measures Following Concussion in Young Adult Athletes” released today in the journal, JAMA Network Open. The findings indicate that digital measurement of the HeadPulse, using MindRhythm’s proprietary…

EMS World: How a Simple Headset Can Solve the Triage Problem in Stroke

By John Keane | July 20, 2023 |

In an article published by EMS World back in June of 2021, it was postulated that MindRhythm’s rapid, disposable, noninvasive Harmony headset could detect Large Vessel Occlusion strokes in the field.  At the time, MindRhythm had preliminary, hospital-based data suggesting the device could accurately identify LVO strokes.  However, the company felt strongly that it was important to…

MindRhythm Announces First Patient Enrolled in Pivotal Study of Novel Harmony™ Device for Rapid Detection of Stroke

By Beth Johnson | June 20, 2023 |

CUPERTINO, CALIFORNIA, USA, June 20, 2023/EINPresswire.com/ — MindRhythm Inc, in partnership with Wayne State University School of Medicine in Detroit, Michigan, today announced that the first patient has been enrolled in the pivotal portion of its HeadPulse for Ischemic Stroke Detection Prehospital Study (EPISODE-VS). EPISODE-VS is designed to validate that the use of MindRhythm’s proprietary Harmony headset…

CEO John Keane Featured on NPR for Comment on SVB Crisis and Its Impact on Emerging Businesses

By Beth Johnson | April 3, 2023 |

Days after Silicon Valley Bank’s collapse prompted customers to line up in order to get their money out, the California bank is asking them to come back. “The number one thing you can do to support the future of this institution is to help us rebuild our deposit base, both by leaving deposits with Silicon Valley Bridge…

The Journal of Stroke Vascular and Interventional Neurology Publishes EPISODE-PS Initial Trial Results

By Beth Johnson | March 16, 2023 |

CUPERTINO, CALIFORNIA, UNITED STATES, March 16, 2023 /EINPresswire.com/ — MindRhythm Inc, in partnership with Wayne State University School of Medicine in Detroit, Michigan, today announces the first publication of results from the hEadPulse for Ischemic StrOke DEtection Prehospital Study (EPISODE-PS) trial.  The EPISODE-PS trial was designed to evaluate the use of MindRhythm’s proprietary Harmony headset…

MindRhythm Initiates Pivotal Portion of Prehospital Stroke Trial

By Beth Johnson | February 15, 2023 |

CUPERTINO, CALIFORNIA, UNITED STATES, February 14, 2023 /EINPresswire.com/ — MindRhythm Inc, in partnership with Wayne State University School of Medicine in Detroit, Michigan, today announces the conclusion of phase I and initiation of the pivotal portion of its hEadPulse for Ischemic StrOke DEtection Prehospital Study (EPISODE-VS). The EPISODE trial is designed to evaluate the use of MindRhythm’s…

MindRhythm Expands Stroke License to Include Diagnosis and Recovery From Concussion

By Beth Johnson | October 26, 2022 |

MindRhythm, a medical device technology company focused on preventing neurological injury, announces today the expansion of its exclusive worldwide stroke licensing agreement with University of California San Francisco (UCSF) to include concussion. The agreement was originally executed in December 2020 to support the successful development of MindRhythm’s Harmony headset for the detection of stroke following…

MindRhythm Expands EMS Stroke Trial to California

By Beth Johnson | October 11, 2022 |

MindRhythm, a medical device technology company focused on preventing neurological injury, announces today the expansion of part 1 of its first multicenter clinical trial in stroke to 2 additional sites in California. The trial is based out of Wayne State University in Detroit, in partnership with Henry Ford, Detroit Receiving, Sinai-Grace, and Ascension St. John…